latest news in companies
Rising Costs and AI Demand Fuel Bezos’ Vision for Cloud-Based Computing
Seattle, Thursday, 15 January 2026.
Amazon’s founder views personal hardware as antiquated, likening local PCs to museum artifacts. With AI demands straining global component supplies and spiking DRAM prices, the industry is accelerating a strategic pivot toward centralized, subscription-based cloud computing, effectively ending the era of hardware ownership.
Strategic Win for Tonner Drones as Partner Elistair Joins French Defense Initiative
Paris, Thursday, 15 January 2026.
Tonner Drones’ partner Elistair has been selected for France’s Project Pendragon, an initiative merging tethered drones with AI-driven ground vehicles. This January 15, 2026 announcement marks a pivotal validation of Tonner’s defense-sector investment strategy.
Stagwell Secures Strategic OPPO Partnership to Lead Integrated Marketing in Singapore
Singapore, Thursday, 15 January 2026.
OPPO selects Stagwell’s Allison Worldwide and Assembly to unify Singapore operations, leveraging the STAGE AI engine to blend public relations with data-driven media performance for measurable growth.
NTSB Reveals Boeing Dismissed Defect Risk Years Before Fatal UPS Crash
Louisville, Thursday, 15 January 2026.
NTSB investigators have determined that Boeing identified the specific engine mount flaw behind the fatal 2025 UPS crash nearly 15 years ago. Critically, the manufacturer previously deemed the defect a non-safety issue despite multiple known failures, raising urgent questions about historical oversight and risk assessment.
Kathleen Kennedy Steps Down as Lucasfilm President After $5.6 Billion Tenure
San Francisco, Friday, 16 January 2026.
Kathleen Kennedy departs Lucasfilm after a 13-year tenure that amassed over $5.6 billion in box office revenue. Dave Filoni and Lynwen Brennan will succeed her, bifurcating creative and business leadership.
OS Therapies Files for Animal Health Spinoff to Unlock Veterinary Market Value
New York, Wednesday, 14 January 2026.
On January 14, 2026, OS Therapies (OSTX) took a decisive step to unlock shareholder value by filing a Form S-1 to spin off its subsidiary, OS Animal Health, as an independent public entity. This strategic move aims to capitalize on the booming veterinary oncology market, projected to reach $4.77 billion by 2034. Under the proposed plan, current OSTX investors are positioned to receive one share of the new animal health company for every ten shares held, effectively creating a direct stake in a specialized pipeline focused on canine osteosarcoma. By separating these veterinary assets from its human immunotherapy programs, OS Therapies intends to streamline its focus while OS Animal Health pursues a distinct listing on the NYSE American or Nasdaq in the first half of 2026. This restructuring coincides with the company securing $7.53 million in fresh capital to support regulatory advancements.
Calavo Growers Reports Major Profit Turnaround Ahead of Mission Produce Acquisition
Santa Paula, Wednesday, 14 January 2026.
Despite revenue headwinds, Calavo delivered a massive 192 percent surge in full-year net income, solidifying its financial turnaround just as Mission Produce agrees to acquire the company.